ALACHUA, Fla., Jan. 24 /PRNewswire-FirstCall/ -- Regeneration Technologies, Inc. (RTI) , the Florida-based processor of orthopedic, cardiovascular and other biologic implants, will hold an analyst reception on Tuesday, March 21, 2006, at 5:30 p.m. Central Time during the American Academy of Orthopedic Surgeons Conference (AAOS), held in Chicago, Ill. The reception will be held at the Four Seasons Hotel Chicago, located at 120 East Delaware Place, Chicago, Ill.
Brian K. Hutchison, chairman, president and CEO of RTI, will be joined by his management team for presentations and product overviews. Buy-side and sell-side analysts interested in the RTI story are encouraged to attend.
RTI will hold a simultaneous audio web cast of the meeting, which can be accessed through the investor section of RTI’s web site at http://www.rtix.com . The meeting also can be accessed by telephone by dialing 800-857-1738, passcode RTIX. A telephone replay of the call will be available through April 20, 2006, and can be accessed by calling 800-219-6387; the replay will also be available at http://www.rtix.com .
About Regeneration Technologies, Inc.
RTI processes allograft and xenograft tissue into shaped implants for use in orthopedic, cardiovascular and other surgeries with a commitment to science, safety and innovation.
RTI also holds the patents on BioCleanse(R), the only proven tissue sterilization process validated to eliminate viruses, bacteria, fungi and spores from tissue without impacting the structural or biomechanical integrity of the tissue. The company has distributed more than 650,000 allograft implants sterilized with the BioCleanse process with zero incidence of infection. RTI is accredited by the American Association of Tissue Banks and was named a 2004 Technology Pioneer by the World Economic Forum.
Except for historical information, any statements made in this press release about the company’s anticipated financial results, future operational results, regulatory approvals or changes to the company’s agreements with its distributors are forward-looking statements subject to risks and uncertainties, such as those described in the company’s public filings on file with the Securities and Exchange Commission. Actual results may differ materially from anticipated results reflected in these forward-looking statements. Copies of the company’s SEC filings may be obtained by contacting the company or the SEC or by visiting RTI’s web site at http://www.rtix.com or the SEC’s web site at http://www.sec.gov .
Regeneration Technologies, Inc.
CONTACT: Wendy Crites Wacker, APR, Corporate Communications, RegenerationTechnologies, Inc., +1-386-418-8888
Web site: http://www.rtix.com/
